Blue Square Asset Management LLC Buys 248 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Blue Square Asset Management LLC boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,150 shares of the financial services provider’s stock after purchasing an additional 248 shares during the quarter. iShares Biotechnology ETF comprises 1.3% of Blue Square Asset Management LLC’s holdings, making the stock its 27th largest holding. Blue Square Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $2,664,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. PVG Asset Management Corp purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at $415,000. Huntington National Bank raised its stake in iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares during the last quarter. National Bank of Canada FI boosted its holdings in iShares Biotechnology ETF by 5.9% in the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after acquiring an additional 229 shares in the last quarter. First Financial Bank Trust Division purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $204,000. Finally, Thrive Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at about $445,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.7 %

Shares of iShares Biotechnology ETF stock opened at $137.30 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company has a 50 day moving average price of $136.04 and a 200 day moving average price of $141.80.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.